BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5850 related articles for article (PubMed ID: 2370914)

  • 1. Amplification of N-myc oncogene in human melanoma cells.
    Bauer J; Sokol L; Stríbrná J; Kremen M; Krajsová I; Hausner P; Hejnar P
    Neoplasma; 1990; 37(3):233-8. PubMed ID: 2370914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
    Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
    Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.
    Treszl A; Adány R; Rákosy Z; Kardos L; Bégány A; Gilde K; Balázs M
    Cytometry B Clin Cytom; 2004 Jul; 60(1):37-46. PubMed ID: 15221868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. myc gene amplification and expression in primary human neuroblastoma.
    Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
    Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
    Jin Y; Burns FJ; Garte SJ
    Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
    Saksela K; Bergh J; Nilsson K
    J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of myc gene amplification in human somatic cell hybrids.
    Iman DS; Shay JW
    Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.
    Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Felber M; Sawey MJ
    Cancer Res; 1990 May; 50(10):3073-7. PubMed ID: 2185880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
    Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z
    Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
    Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I
    Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma.
    Adelaide J; Mattei MG; Marics I; Raybaud F; Planche J; De Lapeyriere O; Birnbaum D
    Oncogene; 1988 Apr; 2(4):413-6. PubMed ID: 3283658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
    Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
    Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
    Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
    Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
    Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
    Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the L-myc gene is under positive control by short-lived proteins.
    Saksela K
    Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines.
    Johnson BE; Makuch RW; Simmons AD; Gazdar AF; Burch D; Cashell AW
    Cancer Res; 1988 Sep; 48(18):5163-6. PubMed ID: 2842046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 293.